(2aS,2a1S,5S,5aR,6S,9aR)-8-benzyl-2a-isopropyl-5-(pyrimidin-2-yloxy)-2-tosyldodecahydro-6,9a-epoxyazepino[3,4,5-cd]indole

ID: ALA5287673

Max Phase: Preclinical

Molecular Formula: C32H38N4O4S

Molecular Weight: 574.75

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  Cc1ccc(S(=O)(=O)N2C[C@@]34CN(Cc5ccccc5)C[C@@H](O3)[C@H]3[C@@H](Oc5ncccn5)CC[C@]2(C(C)C)[C@H]34)cc1

Standard InChI:  InChI=1S/C32H38N4O4S/c1-22(2)32-15-14-26(39-30-33-16-7-17-34-30)28-27-19-35(18-24-8-5-4-6-9-24)20-31(40-27,29(28)32)21-36(32)41(37,38)25-12-10-23(3)11-13-25/h4-13,16-17,22,26-29H,14-15,18-21H2,1-3H3/t26-,27+,28+,29+,31+,32-/m0/s1

Standard InChI Key:  PZVWNDUYDFTWQB-JBNIYKNQSA-N

Molfile:  

 
     RDKit          2D

 44 50  0  0  0  0  0  0  0  0999 V2000
   -1.4271    1.0509    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7127    0.6384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0994    0.0862    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3728    1.0733    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.0706    1.9731    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3143    2.7613    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7127    1.4637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.7127    2.2887    0.0000 H   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4274    1.8763    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4274    2.7013    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1420    1.4637    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1420    0.6384    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.4274    0.2258    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3478    0.0122    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.9312    0.5956    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5882   -0.7769    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2558   -0.5813    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8392   -1.1647    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   -2.6642   -1.1647    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2524   -0.4488    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.6257   -1.9616    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.2115   -2.5474    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.9935   -3.3426    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.2001   -3.5536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9866   -4.3505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.6166   -2.9700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8288   -2.1753    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.4352   -0.6676    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7341    1.7901    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0943    1.0511    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9193    1.0511    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7342    0.3168    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3317    1.7655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1418    3.1138    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8565    2.7015    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5684    3.1134    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.5684    3.9386    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.8583    4.3505    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1418    3.9423    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.9194    2.4802    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3314    3.1921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1566    3.1921    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5684    2.4819    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.1603    1.7655    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  1
  2  3  1  0
  3  4  1  6
  5  4  1  0
  5  6  1  6
  7  5  1  0
  2  7  1  0
  7  8  1  1
  7  9  1  0
  9 10  1  6
 11  9  1  0
 11 12  1  0
 12 13  1  0
  2 13  1  0
 13 14  1  1
 14 15  1  0
 14 16  1  0
 13 17  1  0
 17 18  1  0
 18 19  2  0
 18 20  2  0
 18 21  1  0
 21 22  1  0
 22 23  2  0
 23 24  1  0
 24 25  1  0
 24 26  2  0
 26 27  1  0
 27 21  2  0
 28 17  1  0
  3 28  1  0
  5 29  1  0
 29 30  1  0
 30 31  1  0
 30 32  1  0
  3 32  1  0
 31 33  1  0
 10 34  1  0
 35 34  2  0
 36 35  1  0
 37 36  2  0
 38 37  1  0
 39 38  2  0
 34 39  1  0
 40 33  2  0
 41 40  1  0
 42 41  2  0
 43 42  1  0
 44 43  2  0
 33 44  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5287673

    ---

Associated Targets(non-human)

SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 574.75Molecular Weight (Monoisotopic): 574.2614AlogP: 4.31#Rotatable Bonds: 7
Polar Surface Area: 84.86Molecular Species: NEUTRALHBA: 7HBD:
#RO5 Violations: 1HBA (Lipinski): 8HBD (Lipinski): #RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 6.64CX LogP: 4.75CX LogD: 4.69
Aromatic Rings: 3Heavy Atoms: 41QED Weighted: 0.42Np Likeness Score: -0.34

References

1. Hassan H, Chiavaralli J, Hassan A, Bedda L, Krischuns T, Chen KY, Li ASM, Delpal A, Decroly E, Vedadi M, Naffakh N, Agou F, Mallart S, Arafa RK, Arimondo PB..  (2023)  Design and synthesis of naturally-inspired SARS-CoV-2 inhibitors.,  14  (3): [PMID:36970153] [10.1039/d2md00149g]

Source